Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Joe Krupa who wrote (5799)	11/19/2000 5:19:20 PM
From: john.d	Read Replies (2) \| Respond to of 14101

Joe, <say that we are in fact going to be doing a financing in the low $4's, in the next week.> I can see why an institution would like to do a financing at these prices, but why would Dimethaid do one, when we are supposedly on the verge of UK approval? ... and expecting a pot of cash from an marketing partner immediately after. If we did a financing next week that would be sign to me that all is not well with the UK approval. That further suggests that the risk level of an investment in Dimethaid is rising. Things are really coming to a head here, Pennsaid in production, with no marketing partner or UK approval and limited cash in the bank..Rebecca is truley a high risk player and it is a bit worrisome. You do have to seriously wonder why a marketing partner has not been willing to put up the cash weeks ago with approval supposedly "imminent"????? Could this mean that approval is not as sure a thing as we all think it is....... John